CompletedN/Aketamine

Ketamine Anesthesia in Electroconvulsive Therapy

Sponsored by Mayo Clinic

NCT ID
NCT01367119
Target Enrollment
38 participants
Start Date
2011-05
Est. Completion
2012-03

About This Study

Does the use of ketamine as the anesthetic medication in electroconvulsive therapy (ECT) accelerate the antidepressant effect of ECT? The study hypothesis was that depressed subjects receiving ECT with ketamine as the anesthetic agent would demonstrate a faster rate of improvement, defined as lower depression ratings after the second ECT than depressed patients receiving ECT with the usual anesthetic agent.

Conditions Studied

Depression

Interventions

  • Ketamine
  • methohexital

Eligibility

Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion criteria:

* Diagnosis of depression, either unipolar or bipolar
* Subjects receiving ECT at the Mayo Clinic

Exclusion criteria:

* Subjects not giving their own consent to ECT
* Subjects with schizophrenia, schizoaffective disorder, or dementia
* Subjects diagnosed with a major neurological disorder such as epilepsy, Parkinson disease, multiple sclerosis, or a neurodegenerative dementia.

Study Locations (1)

Mayo Clinic in Rochester
Rochester, Minnesota, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Ketamine Anesthesia in Electroconvulsive Therapy | Huxley